
Brain cancer therapy that kills tumor cells with an adenovirus heads for phase 2 trial
After seeing “tremendous efficacy” in a phase 1 study, a cancer drug firm is preparing for what it thinks will be a phase 2 pivotal study early next year of its virus therapy for brain tumors. DNAtrix Inc.’s technology is an oncolytic agent, meaning it’s a virus engineered to destroy cancer cells in the body […]